Evidence map›Paper›PMID 29730700›Full record

ArticlePsychopharmacology2018

Risk-seeking for losses is associated with 5-HTTLPR, but not with transient changes in 5-HT levels.

Philipp T Neukam, Nils B Kroemer, Yacila I Deza Araujo, Lydia Hellrung, Shakoor Pooseh, Marcella Rietschel, Stephanie H Witt, Uwe Schwarzenbolz, Thomas Henle, Michael N Smolka

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Genetics of Risk Aversion: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  2. Trial
  3. Trial
  4. Differential susceptibility effects of theFrontiers in psychiatry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. The Role of Tryptophan and Tyrosine in Executive Function and Reward Processing.International journal of tryptophan research : IJTR · 2020
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Philipp T NeukamDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
Nils B KroemerDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
Yacila I Deza AraujoDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
Lydia HellrungDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
Shakoor PoosehDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
Marcella RietschelDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Stephanie H WittDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Uwe SchwarzenbolzInstitute of Food Chemistry, Technische Universität Dresden, Dresden, Germany.
Thomas HenleInstitute of Food Chemistry, Technische Universität Dresden, Dresden, Germany.
Michael N SmolkaDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany. michael.smolka@tu-dresden.de.

Funding

Deutsche Forschungsgemeinschaft SFB 940/1Deutsche Forschungsgemeinschaft SFB 940/2Deutsche Forschungsgemeinschaft SM80/7-1Deutsche Forschungsgemeinschaft SM80/7-2
6 · The paper itself

Abstract

rationaleSerotonin (5-HT) plays a key role in different aspects of value-based decision-making. A recent framework proposed that tonic 5-HT (together with dopamine, DA) codes future average reward expectations, providing a baseline against which possible choice outcomes are compared to guide decision-making.

objectivesTo test whether high 5-HT levels decrease loss aversion, risk-seeking for gains, and risk-seeking for losses.

methodsIn a first session, 611 participants were genotyped for 5-HTTLPR and performed a mixed gambles (MGA) task and two probability discounting tasks for gains and losses, respectively (PDG/PDL). Afterwards, a subsample of 105 participants (44 with S/S, 6 with S/L, 55 with L/L genotype) completed the pharmacological study using a crossover design with tryptophan depletion (ATD), loading (ATL), and balanced (BAL) conditions. The same decision constructs were assessed.

resultsWe found increased risk-seeking for losses in S/S compared to L/L individuals at the first visit (p = 0.002). Neither tryptophan depletion nor loading affected decision-making, nor did we observe an interaction between intervention and 5-HTTLPR genotype.

conclusionOur data do not support the idea that transient changes of tonic 5-HT affect value-based decision-making. We provide evidence for an association of 5-HTTLPR with risk-seeking for losses, independent of acute 5-HT levels. This indicates that the association of 5-HTTLPR and risk-seeking for losses is mediated via other mechanisms, possibly by differences in the structural development of neural circuits of the 5-HT system during early life phases.

Indexed as

Risk-TakingAdultAntidepressive Agents, Second-GenerationBehaviorCross-Over StudiesDecision MakingDouble-Blind MethodFemaleGamblingGenotypeHumansMaleProbabilityRewardSerotoninSerotonin Plasma Membrane Transport ProteinsAntidepressive Agents, Second-GenerationSerotoninSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, humanTryptophan5-HTTLPRAcute tryptophan interventionDecision-makingMixed gamblesProbability discounting

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.